AIDS in era of antiretrovirals

Confronting the deadly pandemic

An estimated 1 million people die each year from HIV/AIDS, while nearly 2 million people become newly infected with the virus.

Approximately 36.9 million people were living with the human immunodeficiency virus (HIV) at the end of 2017, the majority of them in sub-Saharan Africa. While there is no cure for HIV/AIDS, a combination of drugs, known as antiretrovirals (ARVs), enable people to live longer, healthier lives. The cost of first-line drugs are now cheaper than ever, but efforts are still needed to ensure everyone who is living with HIV receives treatment. Over 15 million people missed out on receiving treatment in 2017.


MSF Access Campaign

Quick Facts


MSF says pharmaceutical industry must keep its promise

Project Update 5 Dec 2000

The crippled continent

Project Update 2 Dec 2000

Glaxo stops Africans buying cheap Aids drugs

Project Update 2 Dec 2000

"Treatment exists, but at unaffordable prices for most of the patients"

Project Update 1 Dec 2000

WHO's "massive effort" is not aggressive enough, says MSF

Press Release 4 Oct 2000
El Salvador

MSF supports HIV/AIDS activist groups in El Salvador

Project Update 13 Sep 2000

AIDS prevention in Mongolia

Project Update 1 Dec 1999

Top Ten Under-Reported Humanitarian Stories of 1998

Statement 16 Dec 1998

We produce important research based on our field experience. So far, we have published articles in over 100 peer-reviewed journals. These articles have often changed clinical practice and have been used for humanitarian advocacy. Read all our HIV/AIDS-related articles on our dedicated Field Research website.

Visit site
Advanced HIV management in Homa Bay